Stock Market Today, Dec. 19: NYSE Halts Infosys Trading After ADRs Spike

Infosys ADRs exploded over 50% intraday on Friday, prompting a brief NYSE trading halt and trading volume of 115.6 million shares — roughly 738% above the three‑month average of 13.8 million. U.S.-listed volatility contrasted with Indian-listed shares (up ~0.7%) and more modest moves in peers (Cognizant +1.97%, Wipro +6.99%), raising concerns about ADR market structure rather than company fundamentals; broader U.S. indices were higher (S&P 500 +0.88%, Nasdaq +1.31%). The episode signals elevated short-term trading risk for ADR holders and potential scrutiny of cross-listing/market-structure issues for foreign shares listed in the U.S.

Analysis

Market structure: The 50% intraday spike in INFY ADRs (115.6m vs 13.8m avg, +738%) highlights a liquidity and creation/redemption breakdown in ADR mechanics — winners are short-term retail and volatility-focused desks; losers include passive ADR holders, ETF issuers and market-makers stuck hedging basis risk. Expect ADR-specific order-flow to dominate price vs. fundamental Indian shares (INFY INR +0.7%), creating repeated short-term dislocations of 10–30% within days until arbitrage pathways reopen.

Risk assessment: Tail risks include NYSE/SEC rule changes on ADR trading or tightened creation/redemption (3–6 months) and operational settlement failures that could freeze ADR liquidity; immediate risk (days) is stop-run volatility and option gamma squeezes. Hidden dependencies: hedges in USD/INR forwards and Indian onshore liquidity; a 1–2% INR move against INR could magnify P&L for hedged ADR positions in 24–72 hours.

Trade implications: Tactical plays favor relative-value and volatility trades: pair long CTSH (CTSH) / short INFY ADR to isolate ADR premium, and options trades that buy volatility (30–60 day straddles) or buy protective put spreads if holding ADRs. Time windows: expect mean reversion 3–10 trading days, elevated IV and volume for 4–8 weeks; regulatory outcomes may take 3–6 months.

Contrarian angle: Consensus frames this as structural risk only; investors with access to cross-list arbitrage can earn persistent alpha because India-listed INFY barely moved. Historical parallels: China ADR dislocations (2020–22) showed reversion once settlement friction eased. Unintended consequence: forced derisking by ETFs could create repeat liquidity vacuums and trading opportunities for liquidity providers.

Key Decisions for Investors

• If you can access both listings, implement a pair trade: go long Cognizant (CTSH) equal-weight and short Infosys ADR (INFY) sized to 1.5% of portfolio each; target capture = 8–15% relative move within 4–8 weeks, stop-loss at 6% adverse move in either leg.
• Do not initiate outright long INFY ADR at spike levels. Consider establishing up to 2% long INFY only on a retracement ≥20% from the intraday high within 3 trading days, with a hard stop at 12% below entry and a 4–8 week time horizon for mean reversion.
• Buy volatility: purchase 30–60 day ATM straddles on INFY (or 30-day 7–10% OTM strangles if IV>historical 30-day by >40%) sized to 0.5–1.0% of portfolio to hedge further ADR dislocations; if IV remains elevated, convert to calendar spreads into 60–90 day tenors.
• Reduce passive ADR exposure to India by ~20% over the next 30 days, reallocating proceeds to Indian-listed large-caps (e.g., TCS on NSE) or US-listed peers (CTSH) to lower ADR structural tail risk pending regulator guidance over 3–6 months.